You have read all your free articles, to continue reading subscribe to read the rest of this content.
The first day of trading on Nasdaq Stockholm’s main market is 27 March 2020. March 18, 2020 that Nasdaq Stockholm’s listing committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market. On 23 March, the prospectus that has been prepared by theAlready a subscriber…
Recipharm and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, LiprocaDepot, at Recipharm in Solna. The manufacturing line is dedicated to the first product based on LIDDS’ NanoZolidtechnology. Clinical trial material has already been produced and the facAlready a subscriber Login You have read…
Swedish Enzymatica has signed an agreement to acquire Icelandic company Zymetech via a non-cash issue. This acquisition gives Enzymatica international exclusive rights to a patent-protected enzyme, a key ingredient in ColdZyme Mouth Spray, as well as control over production of the enzyme, access Already a subscriber Login You have read…
A biosimilar of Merck's popular arthritis drug Remicade is going for a discount of nearly 70 percent of the branded price in Norway, upsetting conventional wisdom and competitors, according to a FiercePharma article. Finnish drug company Orion Oyj, which licenses the biosimilar Remsima from SouthAlready a subscriber Login You have…
